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The status of efforts to develop experimenta l mode ls 
for drug photosensitivity rea ctions in small mamma ls is 
review ed. Tests w hich a re practical and a lso have a high 
pre dictive value in d et ermining photosen sitivity hazards 
t o man are th e g oal of this r esear ch. The variou s animal 
model system s w hich have been u sed are evaluated wit h 
r esp ect to th ese goals . 
It is widely recognized by both t he la ity and the scientific 
community t hat the int roduction of an innumerable number of 
n ew chemicals into our environment has been a "double-edged" 
sword . Alt hough many of these compounds have contributed 
to improving the "quali ty of life," others have been associated 
w it h hazards. The repor ted undesu'a ble reactions from chemi-
cals h ave ranged from the oncogenic effects of diethylstilbes-
terol in t he offspring of pregnant women [1] to the hepatotoxic 
effects of tetrachlorodibenzo-p-dioxin [2]. 
The number of adverse responses considered to be drug 
p h otosensit ivity reactions account fo r only an exceedingly small 
percentage of the total undesi.rable effects fr om envu'onmental 
ch emicals. However, th e rising incidence and severe disabili ty, 
especially when of the persistent ligh t-reactor type [3], indicate 
t h at increased photobiologic research and developmental ef-
for ts ar e requiTed. P redictive tests are an obvious approach to 
minimize or eliminate those chemicals in which the risk-benefi t 
ratio shows them to be undesu'able to society in general, or to 
an unknowing individual in par ticular . 
Historically, t he term "dr ug photosensit ivity" had been 
widely used in clinical medicine to designate cer tain adverse 
reactions associated with the administration of a medica tion to 
a patient who was subsequently exposed to sunligh t. Al though 
it was originally limi ted to therapeutic agents, its current usage 
has been widely expand ed and now includes a lru'ge group of 
ch emicals found in cosmetics, food preservatives, household 
cleaners , fi'agrances, industrial products and by-pl"Oducts, and 
agricul t ural items [4]. 
This report represents a brief overview of the current status 
in t he development of more effective drug photosensit ivity 
models wit h predictive value. It stresses laboratory mammalian 
m odels and human photosensit ivity test systems. 
HISTORICAL 
E ighty yeru's ago, R aab described a photosensit ivity model 
characterized by loss of motili ty of the cilia of paramecia when 
th ese organisms were exposed to an acridine dye and light. 
Exposure to the dye or light alone evoked no reaction [5]. This 
was not onJy the star t of modern photo biology, bu t also a classic 
d emonstration of t he adverse type of response referred to today 
as "dr ug photosens itivity." Numerous classifications of dJ'ug 
photosensit ivity occurring in ma n have been noted. Table I is 
a composite [6, 7). Other unrecognized forms may also exist but 
have not been sufficien tly r ecognized as distinct ent ities. The 2 
major mechanisms t hat ru'e involved in the pathogenesis of 
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dJ'ug photosensit ivity reactions are "phototoxic" and " photoim-
munologic," The curren t status of testing or assaying photosen-
sit ivity associated with t hese 2 mechanisms will be assessed . 
Chemicals reported to cause phototoxic and photoallergic re-
actions in man ru'e listed in Tables II & III. Mechanisms and 
chemicals involved in other types of drug-induced photosensi-
t ivity (dJ'ug-induced porphyria, lupus, and pellagra) have pre-
viously been reviewed [6). 
DRUG INDUCED P HOTOTOXICITY 
P hototoxic reactions aJ'e the most fTequent a nd best under-
stood type of dJ-ug photosensit ivity r eaction . They can occur in 
100% of the population on first exposm e. Using appropriate 
experimental condi tions, a dose-response curve can be demon-
strated with the incidence of phototoxicity reaction being re-
lated to the concentration of the photosensit izer and the inten-
sity of the appropriate wavelength of light. S imilru'it ies and 
diffe rences between phototoxic and photoallergic reactions are 
summarized in T able IV. 
B iochemical and biologic techniques fo r study ing phototoxic 
drug reacti ons have been of major val ue in elaborating the basic 
photochemical and biophysical principles of photobiology, but 
at present offer inadequate predictive models for ma n. 
B iochemical 
The development of a simple and effecti·ve in vitro laborato ry 
test of predictive value fo r dr ug photosensit ivity of t he photo-
toxic type remains an ideal goal [38). Recent studies by Schor-
thorst, Suw'mond, and deLuster [39] describing biochemical 
alterations in amino acids, glu tathione, and unsatumted fatty 
acid indicate promise. Unfo rtunately, these tests presently do 
not meet the desu'ed predictive standards. 
Single Cell Systems 
Model repor ted useful fo r assaying phototoxicity of com-
pounds have included cell cul tures [40] red blood cells [41], 
paramecia, fungi and viJ'al systems. However , a ll of these test 
systems produce data which fa il to correlate well with the 
occurrence of photosensit ivity reactions in man to the same 
agents. On a subcellular level the specific receptor site for 
phototoxic damage has been shown to involve vru'ious cell ular 
con tituents including the nucleus [42], cytoplasmic organell es 
[43], as well as the cell mem bJ'ane [44 , 45]. T hese too a lt hough 
of basic science interest a re of limited clinical value. Both 
cellular a nd subcellulru' models have been reviewed by Spike 
[46], Morikawa et a l [47] a nd Harber, Baer , and B ickers [48). 
The common denominator in all these assays has been the 
detection of a · biologic or chemical alteration in the system 
associated with the int roduction of a phototoxic agent fo llowed 
by ligh t exposure. H owever, not one of the systems descri bed 
has had t he complete success req uired for a pred ictive model to 
assess the photosensit izing potential of these chemicals in man. 
Some of the systems have produced fa lse-posit ive responses 
while others have fa iled to detect commonJy encoun tered pho-
totox ic agents. These inadeq uacies ru'e due to numerous facto rs, 
incl uding: (a) fa ilure to accou nt for variations in the percuta-
neous a bsorption of potent ial photosen, itizers; (b) failme to 
acco un t for variations in gastrointestinal absorption, cuta neous 
storage, a nd excretion of diffe rent photosensit izers; (c) fa ilure 
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TABLE I. Photosensitivity reaction,,5 to drugs 
Reaction Example Theoretical mechanism 
Drug phototoxicity Psoralen DNA binding 
Drug photoallergy Halogenated Delayed hypersen-
salicylani- sitiv ity 
tides 
Drug-induced porphyria Hexachlorben- H epatic prophyri-
zene nogenesis 
Drug-induced lupus Hydralazine Slow acetylator 
phenotype; 
DNA binding 
Drug-induced pellagra lsonicotinic Altered trypto-
acid phan metabo-
lism 
Depigmentation P-tertiary-bu- Unknown 
ty l phenol 
TABLE II. Chemicals inducing photo toxicity in man 
Chemical 
Aminobenzoic ac id derivatives 
Anthraquinone dyes 
Chlorothiazides 
Chlorpromazine 
Coal tar derivatives 
Anthracene 
Acridine 
Phenanthrene 
Pyrene 
Nalidixic acid 
P henothiazine 
Protripty line 
Psoralens 
Sulfanilamide 
Tetracyclines 
Reference 
8 
9 
10 
11 
12,13 
14 
15 
16 
17,18,19 
20,21 
22,23,24 
TABLE III. Chemiails reported to induce photoallergic reactions in 
man 
Chemical 
Aminobenzoic acids 
Bithionol 
Chlorpromazine (thorazine) 
Chlorpropam ide (d iabinese) 
Fentich lor 
Halogenated sa licylanilides 
J adit 
6-Methylcoumarin 
Musk ambrette 
P romethazine (phenergan) 
Su lfonilamide 
T hiazides 
Reference 
25 
26,27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
to account for hepatic and cutaneous metabolic alteration of 
potential photosensitizers; (d) failure to account for inactivation 
of the photosensitizer by other body constituents. 
Consequently, it is appropriate that this report emphasizes 
mal1?rnalian systems as they more closely approximate condi-
t ions in humans. The relative strengths and weakness of these 
predictive mammalian model will be noted. However, even with 
the use df these systems, which h ave been shown to have a 
higher predictive val ue, there still r emains inherent limitations 
when the phototoxicity data derived from animals IS applied to 
the actual environment conditions encountered by humans. 
EXPERIMENTAL MAMMALIAN ANIMAL MODELS 
DEMONSTRATING PHOTOTOXICITY 
Phototoxicity has been demonstrated with relative ease in 
numerous mammalian animal models induding mice, rats, rab-
bits, swine, and guinea pigs. Table V lists several animal models 
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which have been successfully used to induce photo toxic reac-
tions. Each has relative advantages and disadvantages as noted 
below. 
Mice 
Drug phototoxicity studies by Rothe and Jacobus [49] as well 
as those of Ison and Blank [50] have shown the feasibility of 
using Swiss Webster albino mice. Ison and Blank have dem-
onstrated the superiority of an assay based on intraperitoneal 
injections of phototoxic agents to mice as compared a fungal 
culture model. 
Topical application of photosensitizers and irradiation of 
swiss albino mouse ears has also been assayed. The major 
advantage of this procedure is that in contrast to th e back, 
depilation is unnecessary. Hairless mice studies have recently 
been used [47]; However, theil' major photobiologic use has 
been in oncogenic studies such as the carcinogenic effects of 
ultraviolet light with or without the topical application of 
retinoids. In addition edema of t he tail of mice has been used 
as a measure of phototoxicity [51]. 
Advantages: Mice are relatively inexpensive and easy to 
house and handle. Phototoxic assays can be made on th e basis 
of edema, erythema, and necrosis observed on the ears and tail 
[51]. When hail'less mice are used, no depilating procedures are 
req uired. 
Disadvantages: The thinness of the mouse epidermis as 
compared to man results in a larger percentage of UVB radia-
tion reaching the basal cell layer, connective tissue, and vascu-
lature. This increases the potential for false-positive reactions. 
In addition, false-positive reactions can be obtained following 
minimal trauma to affected sites as compared to other experi-
mental animals such as the guinea pig. It is also more difficult 
to evaluate and assess erythema in mice than guinea pigs. Even 
TABLE IV. Mechanisms of drug-induced photosensitivity : 
Comp arison of plwtotoxic and photoallelgic reactions in test models 
Heaction Phototoxic Photoa Ilergic 
Incidence Usually re la tively high Usually lower 
(theoretically 100%) 
Reaction possible on Yes No 
first exposu re 
Incu bation period nec- No Yes 
essary after fi.rst ex-
posure 
Can persistent light re- No Yes 
action develop 
Cross- reactions to No Frequent 
structurally related 
agents 
Passive transfer No Possible 
Lymphocyte stimula- No Possible 
tion test 
Macrophage migration No Possible 
inhibition test 
TABLE V . Mamma.lian models effective in demonstrating 
photo toxicity 
Mammal 
Mouse (whole body) 
(ear) 
(hairless) 
Rats 
Rabbit 
f ig (miniature) 
Guinea pig (back) 
(ears) 
Example of 
phot.os ens ilizer 
Demethyltetracyc-
line 
Chlorpromazine 
O-dimethylamino 
benzoic acid 
Psoralen 
Psomlen 
Psoralen 
Psomlen 
Demethylchlortetra-
cycline 
Selected references 
(50,47) 
(51) 
(7) 
(47) 
(47,58) 
(53) 
(54) 
(5(;) 
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t hough Ison and Blank reported successful induction of photo-
sensit ization with most of the common photo toxic agents using 
intraperitoneal injections as a test system; the chlorothiazides 
proved to be an exception. 
Rats 
Rats have been used to assay photosensitivity to topical 
agents and to assay changes in porphyrin synthesis which may 
relate to photosensitivity. 
The photo toxic model in rats is similar to the one recently 
described in mice [51J and also measures tail edema. It involves 
the assay of the pho totoxic reaction of the rat tail which is 
excised then weighed wet, and again after drying. This value is 
compared to a control animal that is t reated identically except 
t hat the animal is unirradiated . 
Advantages: A dose-response cW've representing phototoxic 
inflammation can be quantitatively expressed in terms of edema 
for anyone photosensitizing agent. 
Disadvantages: Difficult to make comparisons between dif-
fere nt photosensitizers based on edema response. 
The rat can also be used as a sensitive biologic assay t.o 
measure porphyrin synthesis by quanti tating urinary excretion 
of porphyrins. The indirect induction technique involves sys-
temic administration of nonphotosensitizing agents per se such 
as hexachlorobenzene [52]. 
Advantages: Rats are exquisitely sensi tive and id eally suited 
for hepatic enzyme induction studies [52]. Agents such as 
allylisopropylacetamide, dicarbethoxy-dihydrocollidille, and 
griseofulvin administered as part of the diet can serve as effec-
tive models for studying induction of porphyrins. It is this 
increased rate of synthesis of normal hem e metabolites that in 
selected instances, results in photosensitivity in man. This 
su bject has been reviewed in depth by D e Ma tteis [52]. 
Disadvantages: Use of the rat as an in vivo model is relatively 
expensive and also poses animal ha ndling problems. The actuaJ 
sensitivity of the enzyme induction potential of drugs is too 
great, and the experimental data does not closely correlate with 
findings in ma n. Another disadvantage is that for photobiologic 
studies in rat skin, it is often necessary to depilate the animals, 
a procedure which adds a non physiologic trauma and is diffi-
cult. 
Rabbits 
Data by Morikawa indicate rabbits should be of considerable 
value in screening for photo toxicity of topically applied photo-
sensitizers [47]. These male albino animals weighing 2.5-3.0 kg 
have been used in relatively few published photobiologic stud-
ies. Depilated skin on the back of the animal serves as the test 
site. 
Advantages: Rabbits appear to develop phototoxic reactions 
more readily and respond with greater erythema than do guinea 
pigs [47]. Far superior to mice and rats in terms of sensi tivity 
and ease in assaying erythema. 
Disadvantages: These are relatively large a nd expensive 
animals. Facilities to house large numbers pose a problem as 
compared to mice, rats, and guinea pigs. 
Miniature Swine 
These animals have been used in relatively few published 
studies [53J but appeal' promising. The phototoxic agents stud-
ied have been topically applied to the restrained animals. 
Advantages: Skin thickness, closely approxima te man. Ur-
bach, (personal communication) feels that studies using minia-
t ure pigs for assaying photo toxic damage to the vasculature in 
th e cutis are valuable for investigating the response to 8-me-
t hoxypsoralen and similar agents. 
Disadvantages: Lru'ge and expensive. Require specialized 
animal facilities, and more personnel for experimental proce-
dures. 
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Guinea Pigs 
These are probably the most widely used small laboratory 
ma mmal for studying topical phototoxicity agents [54-58]. Non-
ill bred aJbino animals are commonly used. These are usually of 
the Hartley strain. 
Advantages: Investigators often prefer guinea pigs as they 
are relatively docile, widely available, and have a good erythema 
response to ultraviolet type B radiation. Data correlates well 
with man for vast majority of topical agents. Erythema is 
clearly visible as compared to mice and miniature swine. 
Disadvantages: must be depilated, thinner epidermis than 
man, poor animal for inducing tumors following repetitive drug 
photosensitivity reactions. Cost for purchase and housings ex-
pensive as compared to mice. 
Extensive studies designed to investigate species variation in 
drug photosensitivity responses have been limited. One of the 
most comprehensive of these concerned species differences in 
phototoxic responses a nd was reported by Morikawa [47]. 8-
methoxypsoralen (8-MOP) was used as a reference standard of 
comparison as noted in Table VI. Morikawa et al noted t hat 
the threshold a nd magni tude of phototoxic reaction to B-MOP 
in decreasing order was: miniature swine, hairless mouse, guinea 
pig, rat and rabbit. They also reported that the hair cycle was 
found to influence the photo toxic reaction in rabbit skin. More 
sensitivity to phototoxic agents was noted during telogen than 
anagen phase [47]. 
A comparison of 21 well-known photosensitizers was also 
made by Morikawa in ra bbits and guinea pigs. Data indicated 
that both qualitatively and quantitatively rabbits were more 
sensitive t han guinea p igs in assaying for phototoxicity. 
EXPERIMENTAL HUMAN MODELS FOR 
DEMONSTRATING PHOTOTOXICITY 
Photosensitivity assays in man for predicting the photo toxic 
potential of chemicals has been comprehensively reviewed by 
M aibach and Marzulli [59]. In general these studies can be done 
with relative ease on the lower lumbar area of volunteers, and 
if only small body areas are exposed do not pose an undue 
hazard. However, before human studies are instit uted as a 
precautionary measure toxicity and phototoxici ty studies in 
animals are advised. Table VII lists selected types of human 
assays. Each has relative advantages and disadvantages as 
noted below. . 
Scotch Tape "Stripping" 
This so-called "maximization test" has shown application to 
both phototoxic and photoallergic compounds [60, 61]' A xenon 
TABLE VI. Evaluation of sp ecies difference in photo toxic reaction to 
8-methoxypsoralen {47] 
Species 
Photot.oxic reacliol1 to S·MOP 
0.0025% 0.00 1% 0.005% 
Rabbit " 10/ 00 8/ 10 3/10 
• 8/ 10 1/ 10 0/ 10 
Rat" 10/ 10 9/10 2/ 10 
Mouse" 0/ 10 0110 0/ 10 
Ha irl ess Mouse 1/ 6 0/ 6 0/ 6 
Guinea Pig 10/ ]0 2/ 10 0110 
Miniature Swine 0/ 5 0/ 5 0/ 5 
Phototoxic reaction to 8-methoxypsoralen (8-MOP) was read at 48 hr. 
The hair cycle was at the te logen" and anagenio phase (Morikawa). 
TABLE VII. Assay of phototoxic agents in human models [581 
T echnique 
Scotch tape stripping 
Intradermal injection 
Clinical test (" boat ride") 
Example of 
photosens ilizer 
Eosin 
Chlorothiazides 
T etracyclines 
Refe rence 
60,61 
62 
63, 64 
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lamp is the usual light source and relatively physiologic 
amounts of drug are used. 
Advantages: The instrument used for irradiation studies 
(Solar simulator) emits ultraviolet light similar to sunlight. As 
part of a photobiologic unit it has been used to demonstrate a 
broad range of phototoxic agents in man and animals. 
Disadvantages: The cellophane "stripping" was an ineffec-
tive procedure for demonstrating phototoxicity to sulfonilam-
ide, tetracycline, and chlorothiazide [60]; the system is also 
hard to standardize and may cause pain. The trauma of the 
procedure predisposes to localized bacterial infection. 
Intradermal Injection of Photosensitizer 
The lower back of volunteers receives an intradermal injec-
tion of 0.1 ml aliquots of the photosensitizer in saline solution 
or suspension delivered with a 27-gauge needle. This is followed 
in 10 to 30 min by UV A or UVB radiation. 
Advantages: This system has relative ease of use, wide ap-
plication, and good correlation with actual clinical experience. 
This technique is similar to that used by S. Epstein to classically 
demonstrate phototoxicity to sulfanilamide. There is slight 
pain. 
Disadvantages: Unable to demonstrate phototoxicity to tol-
butamide and chlordiazepoxide [62]. Material must be incor-
porated into liquid vehicle at propel' pH with no primary il'l'itant 
properties. 
Clinical Test 
Direct application to skin of topical phototoxic agents has 
been standardized using lumbar and scrotal tissue [59, 63] with 
known types and amounts of light. 
A more direct and reliable method has been the modified 
usage test as reported by Frost [63]. This clinical model was 
used for assaying phototoxicity to methacycline as compared to 
demethylchlortetracycline and a placebo using natW'al sunlight 
as a light source [94]. The test consisted of a double-blind 
evaluation of erythema 1 day after 50 volunteers had partici-
pated in 6-1u boatride under intense 'Florida sunlight. The 
scores of the test material were thus compared to a known 
photosensitizer and a placebo. 
Advantages: Most accurately duplicates actual exposure con-
ditions in which photosensitivity might occur. In actuality is a 
"usage" test. 
Disadvantages: A relatively large number of volunteers nec-
essary. It is difficult to control or duplicate actual test condition 
in terms of temperature and amount of light exposW'e. 
PHOTO ALLERGIC REACTIONS 
Drug photosensitivity can also be mediated by a photoim-
munologic mechanism. The role of light is restricted to photo-
chemically altering the hapten or causing its combination with 
"carrier" protein. Following formation of this "photoantigen," 
it is believed to be pl'ocessed by macl'ophages and then to come 
in contact with T-cell lymphocytes as in an "ordinary" delayed-
hypersensitivity immunologic response. The complete photoan-
tigen is recognized on subsequent expOSUl'e when "sensitized" 
T-cell lymphocytes are present. An immunological response is 
then initiated which results in erythema in laboratory animals 
and a papulovesicular, eczematous response in man. This hy-
pothesis has been supported by in vitro and animal studies. 
The photoadducts of tetrachlorosalicylanilide and Jadit (4-
chloro-2-hydroxybenzoic acid-N-n-butylamide) in combination 
with ,protein were tested for elicitation of immunologic re-
sponses in in vitro systems and have been found to give positive 
test results [66, 67]. Passive transfer of photosensitivity to 
tetrachlorosalicylanilide using peritoneal mononuclear from 
photosensitized guinea pigs, has been demonstrated [68, ,69]. 
Although many photosensitizing compounds have been cited 
in the clinical literatW'e as mediated by a photoimmunologic 
mechanism (Table III) only a few of these have been verified in 
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experimental models. The most comprehensive data concerning 
photoallergy to halogenated salicylanilides and its derivatives 
being induced in laboratory animals was that of Morikawa et al 
[47]. Classic examples of clinical reports include chlorpromazine 
[70] , bithionol [71], Jadit [72], and promethazine [73]. 
EXPERIMENTAL ANIMAL MODELS 
DEMONSTRATING PHOTOALLERGY 
The successful induction of experimental photoallergic con-
tact dermatitis in guinea pigs was fU'st reported by Schwarz and 
Schwarz-Speck [74] in 1957 with sulfanilamide. Following this 
Vinson and BOJ'selli induced contact photoallergic reactions 
with tetrachlorosalicylanilide [75] which has been confu'med by 
several other groups [47, 68, 69, 76-78]. More recently contact 
photoallergy to musk ambrette [79] and 6-methylcoumarin [80] 
have been induced. 
The guinea pig has been the only experimental animal used 
to demonstrate photosensitivity of the delayed-hypersensitivity 
type in all of the reported animal studies. Hartley strain albino 
guinea pigs (375-425 grn) are ideal. Whenever possible animals 
are kept in individual cages. However, if it is necessary to have 
2 or more animals housed together, females appeal' to be 
preferable as there is likely to be less scratching of phototest 
sites. 
Table VIII lists the techniques of inducing contact photoal-
lergy in guinea pig models. Following induction and a suitable 
incubation period, elicitation has always been accomplished 
with topical application of the photosensitizer followed by ul-
traviolet A radiation. Each model has relative advantages and 
disadvantages as noted below. 
INDUCTION TECHNIQUES 
The typical induction procedure consists of the topical appli-
cation of a relatively high concentration (10 to 100 times more 
than the lowest eliciting concentration) of the photosensitizer 
followed by irradiation. This induction procedure solely in-
volves the nuchal region. Elicitation is restricted to the depi-
lated surface of the back and is repeated 3-5 times during a 7 
day period. 
UVB Irradiation 
This model fust intToduced by Vinson and Borselli [75] has 
undergone numerous modifications and is an excellent one for 
inducing photosensitivity to halogenated salicylanilides and its 
derivatives. It employs the use of both UV A and UVB radiation 
during the induction phase. 
Advantages: Widely established model that has been dupli-
cated in several laboratories [47, 68, 69, 76- 78]. 
Disadvantages: Ineffective in inducing photoallergy to 
methyl coumarin and musk ambrette. Eyes of the investigator 
must be protected (goggles) , against corneal bW'ns from UVB 
exposure. 
TABLE VIII. Techniques used to increase index of photo allergic 
contact dermatitis in g uinea pigs 
Nuchal" techniqu e 
Ultraviolet rad iation (Type 
B) 
Sodium law'yl sulfate 
Skin "stripping" with cello-
phane tape 
Example of photosensi-
tizer 
Halogenated sali-
cylanilides 
Halogenated sali-
cylanilides 
Musk ambrette 
Stripping plus intradermal Musk ambrette 
, injection of Freund's ad- Methyl cou-
juvant marin 
Reference 
47,68,76,77,78 
81 
79 
80 
n These procedures preceed i.rradiation of topically applied chemical 
with ultraviolet (Type A) radiation. 
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Sodium Lauryl Sulfate 
This system introduced by Horio offers promise and should 
be further evaluated [81]. The induction procedure consists of 
t he topical application of a 20% aqueous solution of sodium 
lauryl sulfate to the nuchal area . One hour later the photosen-
sitizer is applied to the same site and immediately followed by 
UV A radiation. This procedure is repeated 5-10 times during a 
IO-day period. 
Advantages: Appears simple and effective. Good index of 
photosensitization to halogenated salicylanilides and bithionol. 
Disadvantages: Linlited reports of usage by photo biologists. 
Skin "Stripping" with Cellophane Tape 
The induction procedure consists of the repeated application 
of cellophane "Scotch" tape to the nuchal site until "glistening" 
is noted. The photosensitizer is then applied after which the 
site is irradiated with UV A. The procedure is repeated 3 to 5 
times during a 7-day period. The rationale of stripping may 
involve increased percutaneous absorption of photosensitizer, 
but the effectiveness of the model may also be related to an 
inflammatory response. 
Advantages: Appears analogous to maximization test in man. 
Was successful for induction of musk ambrette photosensitivity 
in guinea pigs [79]. 
Disadvantages: Ineffective in inducing photoallergy to meth-
ylcoumarin, difficult to standardize. Truck crust often forms on 
nuchal induction site. 
Intradermal Injection of Freund's Adjuvant 
The induction procedure consists of the intradermal injection 
of Freund's adjuvant into the corners of the depilated and 
"stripped" nuchal area. The photosensi t izer is then topically 
applied and removed with acetone 30 min later. Following this, 
t he site is irradiated with UV A. The procedure is repeated 5 
t imes during a lO-day period although Freund's adjuvant is 
employed only the fIrst time. Preliminary studies indicate this 
may be the m ethod of choice [80]. Reservations regard the 
possibility that this system may be an overly sensitive model. 
Advantage: Easy to use and standardize. Has high index of 
photosensitization. 
Disadvantage: May be overly sensitive; has not been suffi-
ciently assessed for false positives. Excellent for inducing pho-
toallergic reactions to halogenated salicylanilides, musk am-
brette, and methyl coumarin [80]. 
EXPERIMENT AL HUMAN MODELS FOR 
DEMONSTRATING PHOTOALLERGY 
In 1968 Willis and Kligman [82, 83] reported the experimental 
induction of photoallergic contact sensitization to halogenated 
salicylanilides and related chemicals in human volunteers. This 
system has been widely reproduced. Unfortunately, it has been 
associated with the induction of persistent light reactors and 
realJy should not be used if a suitable animal model can be 
substituted [82, 83]. 
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